Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Myelodysplastic Syndromes 1Mesonephric Gynecologic Cancer 1Melanoma 1Lung Neoplasms 1Low-Grade Serous Ovarian Cancer 1Low Grade Serous Ovarian Cancer 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Glioblastoma 1Brain Neoplasms 1Advanced Colorectal Cancer 1Adenocarcinoma of Lung 1

Interventions

Magnetic Resonance Spectroscopy 4Surgical Procedures, Operative 3Iodine-131 3Iodine-124 3Biopsy 3selpercatinib 2lenvatinib 2Watchful Waiting 2Thyrotropin Alfa 2Therapeutics 2Nivolumab 2Fluorodeoxyglucose F18 2Cyclophosphamide 2Cetuximab 2Biopsy, Fine-Needle 2trastuzumab deruxtecan 1trametinib 1sintilimab 1sacituzumab govitecan 1repotrectinib 1pralsetinib 1pembrolizumab 1gallium Ga 68 dotatate 1fludarabine phosphate 1defactinib 1dabrafenib 1cemiplimab 1brodalumab 1binimetinib 1anlotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Thyroid Neoplasms × defactinib × Clear all
NCT06007924 2026-03-27

A Study of Avutometinib and Defactinib in People With Thyroid Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
30 enrolled
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡